Disruption of redox homeostasis and carcinogen metabolizing enzymes changes by administration of Vitamin E to rats

Life Sciences

Volumn 145, Issue , 2016, Pages 166-173

  Vivarelli, Fabio ^a   Canistro, Donatella ^a   Franchi, Paola ^a   Sapone, Andrea ^a   Vornoli, Andrea ^b   Della Croce, Clara ^c   Longo, Vincenzo ^c   Lucarini, Marco ^a   Paolini, Moreno ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^c Institute of Agricultural Biology and Biotechnology   (Italy)

Author keywords

Antioxidant enzymes; Chemopreventive agent; Cytochrome P450; Free radical species; Phase II enzymes; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CARCINOGEN; CATALASE; CYTOCHROME P450; CYTOCHROME REDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); UNSPECIFIC MONOOXYGENASE; ANTINEOPLASTIC AGENT; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL FRACTIONATION; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; HOMEOSTASIS; IN VIVO STUDY; KIDNEY; LIVER; MALE; NONHUMAN; OXIDATION REDUCTION REACTION; RAT; XENOBIOTIC METABOLISM; ANIMAL; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; ANTICARCINOGENIC AGENTS; CARCINOGENS; CYTOCHROME P-450 ENZYME SYSTEM; KIDNEY; LIVER; MALE; OXIDATION-REDUCTION; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; VITAMIN E;

EID: 84951838429     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2015.12.033     Document Type: Article

References (80)

1. G.W. Burton, M.G. Traber, R.V. Acuff, D.N. Walters, H. Kayden, L. Hughens, and K.U. Ingold Human plasma and tissue alpha-tocopherol concentrations in response to supplementation with deuterated natural and synthetic vitamin E Am J Clin Nutr. 67 1998 669 684
2. A. Rigotti Absorption, transport, and tissue delivery of vitamin E Mol Aspects Med. 28 2007 423 436
3. J.H. Wu, and K.D. Croft Vitamin E metabolism Mol Aspects Med. 28 2007 437 452
4. J.N. Hathcock, A. Azzi, J. Blumberg, T. Bray, A. Dickinson, B. Frei, I. Jialal, C.S. Johnston, F.J. Kelly, K. Kraemer, L. Packer, S. Parthasarathy, H. Sies, and M.G. Traber Vitamins E and C are safe across a broad range of intakes Am. J. Clin. Nutr. 81 2005 736 745
5. M.J. Stampfer, and W.C. Willett Homocysteine and marginal vitamin deficiency. The importance of adequate vitamin intake J. Am. Med. Assoc. 270 1993 2726 2727
6. H.Y. Huang, and L.J. Appel Supplementation of diets with alpha-tocopherol reduces serum concentrations of gamma- and delta-tocopherol in humans J. Nutr. 133 2003 3137 3140
7. S. Blum, M. Vardi, J.B. Brown, A. Russell, U. Milman, C. Shapira, N.S. Levy, R. Miller-Lotan, R. Asleh, and A.P. Levy Vitamin E reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotype Pharmacogenomics 11 2010 675 684
8. J. Ju, S.C. Picinich, Z. Yang, Y. Zhao, N. Suh, A.N. Kong, and C.S. Yang Cancer-preventive activities of tocopherols and tocotrienols Carcinogenesis 31 2010 533 542
9. E. Niki Do free radicals play causal role in atherosclerosis? Low density lipoprotein oxidation and vitamin E revisited J. Clin. Biochem. Nutr. 48 2011 3 7
10. The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group. Ann. Epidemiol. 4 1994 1 10
11. L.C. Clark, G.F. Combs Jr., B.W. Turnbull, E.H. Slate, D.K. Chalker, J. Chow, L.S. Davis, R.A. Glover, G.F. Graham, E.G. Gross, A. Krongrad, J.L. Lesher Jr., H.K. Park, B.B. Sanders Jr., C.L. Smith, and J.R. Taylor Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group JAMA 276 1996 1957 1963
12. W.J. Blot, J.Y. Li, P.R. Taylor, W. Guo, S. Dawsey, G.Q. Wang, C.S. Yang, S.F. Zheng, M. Gail, G.Y. Li, Y. Yu, B.-q. Liu, J. Tangrea, Y. Sun, F. Liu, J.F. Fraumeni, Y.H. Zhang, and B. Li Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population J. Natl. Cancer Inst. 85 1993 1483 1492
13. P.R. Taylor, and D. Albanes Selenium, vitamin E, and prostate cancer - ready for prime time? J. Natl. Cancer Inst. 90 1998 1184 1185
14. N. Fleshner, W.R. Fair, R. Huryk, and W.D. Heston Vitamin E inhibits the high-fat diet promoted growth of established human prostate LNCaP tumors in nude mice J. Urol. 161 1999 1651 1654
15. D.P. Vivekananthan, M.S. Penn, S.K. Sapp, A. Hsu, and E.J. Topol Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials Lancet 361 2003 2017 2023
16. P.G. Shekelle, S.C. Morton, L.K. Jungvig, J. Udani, M. Spar, W. Tu, M.J. Suttorp, I. Coulter, S.J. Newberry, and M. Hardy Effect of supplemental vitamin E for the prevention and treatment of cardiovascular disease J. Gen. Intern. Med. 19 2004 380 389
17. R.S. Eidelman, D. Hollar, P.R. Hebert, G.A. Lamas, and C.H. Hennekens Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease Arch. Intern. Med. 164 2004 1552 1556
18. J. Stratton, and M. Godwin The effect of supplemental vitamins and minerals on the development of prostate cancer: a systematic review and meta-analysis Fam. Pract. 28 2011 243 252
19. J.M. Gaziano, R.J. Glynn, W.G. Christen, T. Kurth, C. Belanger, J. MacFadyen, V. Bubes, J.E. Manson, H.D. Sesso, and J.E. Buring Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial J. Am. Med. Assoc. 301 2009 52 62
20. E.R. Miller III, R. Pastor-Barriuso, D. Dalal, R.A. Riemersma, L.J. Appel, and E. Guallar Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality Ann. Intern. Med. 142 2005 37 46 (Epub 2004 Nov 10)
21. E.A. Klein, I.M. Thompson Jr., C.M. Tangen, J.J. Crowley, M.S. Lucia, P.J. Goodman, L.M. Minasian, L.G. Ford, H.L. Parnes, J.M. Gaziano, D.D. Karp, M.M. Lieber, P.J. Walther, L. Klotz, J.K. Parsons, J.L. Chin, A.K. Darke, S.M. Lippman, G.M. Goodman, F.L. Meyskens Jr., and L.H. Baker Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT) J. Am. Med. Assoc. 306 2011 1556 1649
22. E.M. Burns, K.L. Tober, J.A. Riggenbach, D.F. Kusewitt, G.S. Young, and T.M. Oberyszyn Differential effects of topical vitamin E and C E Ferulic® treatments on ultraviolet light B-induced cutaneous tumor development in Skh-1 mice PLoS One 8 2013 e63809
23. C. Cohen, J.F. Cardoso, S.B. Garcia, and H. Vannucchi Vitamin E supplementation in chemical colorectal carcinogenesis: a two-edged knife Nutrients 6 2014 3214 3229
24. Q.J. Wu, Y.B. Xiang, G. Yang, H.L. Li, Q. Lan, Y.T. Gao, W. Zheng, X.O. Shu, and J.H. Fowke Vitamin E intake and the lung cancer risk among female nonsmokers: a report from the Shanghai Women's Health Study Int. J. Cancer 136 2015 610 617
25. R.L. Bailey, V.L. Fulgoni III, D.R. Keast, and J.T. Dwyer Dietary supplement use is associated with higher intakes of minerals from food sources Am. J. Clin. Nutr. 94 2011 1376 1381
26. L. Rowe, and E.D. Wills The effect of dietary lipids and vitamin E on lipid peroxide formation, cytochrome P-450 and oxidative demethylation in the endoplasmic reticulum Biochem. Pharmacol. 25 1976 175 179
27. M. Murray In vitro and in vivo studies of the effect of vitamin E on microsomal cytochrome P450 in rat liver Biochem. Pharmacol. 42 1991 1 7
28. Y.A. Sidorova, E.V. Ivanova, A.Y. Grishanova, and V.V. Lyakhovich Dose-dependent effect of alpha-tocopherol on activity of xenobiotic metabolizing enzymes in rat liver Bull. Exp. Biol. Med. 136 2003 38 41
29. M. Paolini, L. Pozzetti, G.F. Pedulli, M. Cipollone, R. Mesirca, and G. Cantelli-Forti Paramagnetic resonance in detecting carcinogenic risk from cytochrome P450 overexpression J. Investig. Med. 44 1996 470 473
30. S. Puntarulo, and A.I. Caderbaum Production of reactive oxygen species by microsomes enriched in specific human cytochrome P450 enzymes Free Radic. Biol. Med. 24 1998 1324 1330
31. A. Sapone, D. Canistro, S. Melega, R. Moles, F. Vivarelli, and M. Paolini On enzyme-based anticancer molecular dietary manipulations J. Biomed. Biotechnol. 2012 2012 1 7
32. Y. Wang, G. Millonig, J. Nair, E. Patsenker, F. Stickel, S. Mueller, H. Bartsch, and H.K. Seitz Ethanol-induced cytochrome P4502E1 causes carcinogenic etheno-DNA lesions in alcoholic liver disease Hepatology 50 2009 453 461
33. C. Bauer, C. Corsi, and M. Paolini Stability of microsomal monooxygenases in murine liver S9 fractions derived from phenobarbital and beta-naphthoflavone induced animals under various long-term conditions of storage Teratog. Carcinog. Mutagen. 14 1995 13 22
34. O.H. Lowry, H.J. Rosenbrough, A.L. Farr, and R.J. Randall Protein measurement with folin phenol reagent J. Biol. Chem. 193 1951 265 275
35. Y.L. Bailey Techniques in Protein Chemistry 1967 Elsevier Amsterdam
36. T. Omura, and R. Sato The carbon monoxide-binding pigment of liver microsomes I. Evidences for its hemoprotein nature J. Biol. Chem. 239 1964 2370 2385
37. D. Canistro, J. Barillari, S. Melega, A. Sapone, R. Iori, E. Speroni, and M. Paolini Black cabbage seed extract affects rat Cyp-mediated biotransformation: organ and sex related differences Food Chem. Toxicol. 50 2012 2612 2622
38. M. Bruce Microsomal NADPH cytochrome c-reductase Methods Enzymol. 10 1967 551 557
39. P. Mazel Experiments illustrating drug metabolism in vitro B.N. LaDu, H.G. Mandel, E.L. Way, Fundamentals of Drug Metabolism and Drug Disposition 1971 The Williams & Wilkins Company Baltimore MD 546 555
40. T. Nash Colorimetric estimation of formaldehyde by means of Hantzsch reaction Biochem. J. 55 1953 416 421
41. L.A. Reinke, and M.L. Mayer p-Nitrophenol hydroxylation. A microsomal oxidation which is highly inducible by ethanol Drug Metab. Dispos. 13 1985 548 552
42. R.A. Lubet, R.T. Mayer, J.W. Cameron, R.W. Nims, M.D. Burke, and T. Wolff pentoxyresorufin: a rapid and sensitive assay for measuring induction of cytochrome(s) P-450 by phenobarbital and other xenobiotics in the rat Arch. Biochem. Biophys. 238 1985 43 48
43. M.D. Burke, S. Thompson, C.R. Elcombe, J. Halpert, T. Haaparanta, and R.T. Mayer Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450 Biochem. Pharmacol. 34 1985 3337 3345
44. A. Aitio A simple and sensitive assay of 7-ethoxycoumarin deethylation Anal. Biochem. 85 1978 488 491
45. W.H. Habig, M.J. Pabst, and W.B. Jakoby Glutathione S-transferase AA from rat liver J. Biol. Chem. 249 1974 7130 7139
46. D. Canistro, C.D. Croce, R. Iori, J. Barillari, G. Bronzetti, G. Poi, M. Cini, L. Caltavuturo, P. Perocco, and M. Paolini Genetic and metabolic effects of gluconasturtiin, a glucosinolate derived from cruciferae Mutat. Res. 545 2004 23 35
47. J. Barillari, R. Iori, M. Broccoli, L. Pozzetti, D. Canistro, A. Sapone, B. Bonamassa, G.L. Biagi, and M. Paolini Glucoraphasatin and glucoraphenin, a redox pair of glucosinolates of brassicaceae, differently affect metabolizing enzymes in rats J. Agric. Food Chem. 55 2007 5505 5511
48. P.I. Mackenzie, and O. Hänninen A sensitive kinetic assay for UDPglucuronosyltransferase using 1-naphthol as substrate Anal. Biochem. 109 1980 362 368
49. C.R. Wheeler, J.A. Salzman, N.M. Elsayed, S.T. Omaye, and D.W. Korte Jr. Automated assays for superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase activity Anal. Biochem. 184 1990 193 199
50. L. Ernster, L. Danielson, and M. Junggren DT diaphorase. I. Purification from the soluble fraction of rat-liver cytoplasm, and properties Biochim. Biophys. Acta 58 1962 171 188
51. L. Valgimigli, G.F. Pedulli, and M. Paolini Measurement of oxidative stress by EPR radical-probe technique Free Radic. Biol. Med. 31 2001 708 716
52. L. Valgimigli, M. Valgimigli, S. Gaiani, G.F. Pedulli, and L. Bolondi Measurement of oxidative stress in human liver by EPR spin-probe technique Free Radic. Res. 33 2000 167 178
53. M. Valgimigli, M. Valgimigli, D. Trerè, S. Gaiani, G.F. Pedulli, L. Gramantieri, and L. Bolondi Oxidative stress EPR measurement in human liver by radical-probe technique. Correlation with etiology, histology and cell proliferation Free Radic. Res. 36 2002 939 948
54. M. Paolini, L. Valgimigli, E. Marchesi, S. Trespidi, and G.F. Pedulli Taking EPR "snapshots" of the oxidative stress status in human blood Free Radic. Res. 37 2003 503 508
55. P. Box, and W.G. Hunter Statistics for Experiments 1978 Wiley New York
56. M.J. Grahama, and B.G. Lake Induction of drug metabolism: species differences and toxicological relevance Toxicology 2008 254 2008 184 191
57. A. Bast Is formation of reactive oxygen by cytochrome P450 perilous and predictable? Trends Pharmacol. Sci. 7 1986 226 227
58. M. Paolini, L. Pozzetti, G.F. Pedulli, M. Cipollone, R. Mesirca, and G. Cantelli-Forti Paramagnetic resonance in detecting carcinogenic risk from cytochrome P450 overexpression J. Investig. Med. 44 1996 470 473
59. C. Rodriguez-Antona, A. Gomez, M. Karlgren, S.C. Sim, and M. Ingelman-Sundberg Molecular genetics and epigenetics of the cytochrome P450 gene family and its relevance for cancer risk and treatment Hum. Genet. 127 2010 1 17
60. D.W. Nebert Identification of genetic differences in drug metabolism: prediction of individual risk of toxicity or cancer Hepatology 14 1991 398 401
61. C.C. McIlwain, D.M. Townsend, and K.D. Tew Glutathione S-transferase polymorphisms: cancer incidence and therapy Oncogene 25 2006 1639 1648
62. K.J. Wolfe, J.K. Wickliffe, C.E. Hill, M. Paolini, M.M. Ammenheuser, and S.Z. Abdel-Rahman Single nucleotide polymorphisms of the DNA repair gene XPD/ERCC2 alter mRNA expression Pharmacogenet. Genomics 17 2007 897 905
63. T.N. Sergentanis, and K.P. Economopoulos GSTT1 and GSTP1 polymorphisms and breast cancer risk: a meta-analysis Breast Cancer Res. Treat. 121 2010 195 202
64. U.M. Zanger, and M. Schwab Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation Pharmacol. Ther. 138 2013 (Epub 2013 Jan 16)
65. N.J. Hodges, R.M. Green, J.K. Chipman, and M. Graham Induction of DNA strand breaks and oxidative stress in HeLa cells by ethanol is dependent on CYP2E1 expression Mutagenesis 22 2007 189 194
66. A. León-Buitimea, L. Rodríguez-Fragoso, F.T. Lauer, H. Bowles, T.A. Thompson, and S.W. Burchiel Ethanol-induced oxidative stress is associated with EGF receptor phosphorylation in MCF-10A cells overexpressing CYP2E1 Toxicol. Lett. 209 2012 161 165
67. M.E. Elsherbiny, and D.R. Brocks The ability of polycyclic aromatic hydrocarbons to alter physiological factors underlying drug disposition Drug Metab. Rev. 43 2011 457 475
68. W. Huang, J. Zhang, M. Wahington, J. Liu, J.M. Parant, G. Lozano, and D.D. Moore Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor Mol. Endocrinol. 19 2005 1646 1653
69. P.A. Cerutti Prooxidant states and tumor promotion Science 227 1985 375 381
70. J.E. Klaunig, and L.M. Kamendulis The role of oxidative stress in carcinogenesis Annu. Rev. Pharmacol. Toxicol. 44 2004 239 267
71. J.R. Marshall Beta-carotene: a miss for epidemiology J. Natl. Cancer Inst. 91 1999 2068 2069
72. I.M. Lee, N.R. Cook, J.E. Manson, J.E. Buring, and C.H. Hennekens Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study J. Natl. Cancer Inst. 91 1999 2102 2106
73. H. Vainio Chemoprevention of cancer: lessons to be learned from beta-carotene trials Toxicol. Lett. 112 2000 513 517
74. M. Paolini, G. Cantelli-Forti, P. Perocco, G.F. Pedulli, S.Z. Abdel-Rahman, and M.S. Legator Co-carcinogenic effect of beta-carotene Nature 398 1999 760 761
75. B. Halliwell The antioxidant paradox Lancet 355 2000 1179 1180
76. J.M. Gutteridge, and B. Halliwell Antioxidants: Molecules, medicines, and myths Biochem. Biophys. Res. Commun. 393 2010 561 564
77. R.L. Bailey, J.J. Gahche, P.E. Miller, P.R. Thomas, and J.T. Dwyer Why US adults use dietary supplements JAMA Intern. Med. 173 2013 355 361
78. M. Wenner Moyer Nutrition: vitamins on trial Nature 510 2014 462 464
79. B. Halliwell The antioxidant paradox: less paradoxical now? Br. J. Clin. Pharmacol. 75 2013 637 644
80. J.D. Potter The failure of cancer chemoprevention Carcinogenesis 35 2014 974 982